Local Infusion is the First Ambulatory Infusion Center to Infuse Lumvoa™

Local Infusion, the fastest growing ambulatory infusion provider in the United States, today announced it is the first ambulatory infusion center in the United States to infuse Lumvoa™ (veligrotug-vvze), a newly FDA-approved thyroid eye disease (TED) treatment. The post Local Infusion is the First Ambulatory Infusion Center to Infuse Lumvoa™ appeared first on Local Infusion .